Euphorbia ebracteolata Hayata (Euphorbiaceae): A systematic review of its traditional uses, botany, phytochemistry, pharmacology, toxicology, and quality control

Ting Yang,Jun He,Yu Yan,Wen-Wen Lian,Cong-Yuan Xia,Jie-Kun Xu,Wei-Ku Zhang

DOI: https://doi.org/10.1016/j.phytochem.2021.112736

IF: 3.8

2021-06-01

Phytochemistry

Abstract:<p><em>Euphorbia ebracteolata</em> Hayata, as a traditional medicine, is widely distributed in China, Korea and Japan. In China, the dried root of this plant is named 'langdu'. It is traditionally used to treat oedema, skin ulcers, abdominal distension, cough, asthma, tuberculosis swelling and other diseases. Previous studies have found that the chemical constituents of <em>E. ebracteolata</em> are mainly concentrated in terpenoids, acetophenones, and flavonoids. Both extracts and pure compounds from <em>E. ebracteolata</em> were found to possess many pharmacological activities, such as anticancer, anti-inflammatory, antiviral, and antimicrobial effects. In addition, it was reported that <em>E. ebracteolata</em> shows toxicity. To provide inspiration for further in-depth studies on this plant, this review will provide a timely and systematic summary of <em>E. ebracteolata</em> in traditional uses, phytochemistry, pharmacology toxicology, and quality control.</p>

biochemistry & molecular biology,plant sciences

What problem does this paper attempt to address?

The problem this paper attempts to address is a comprehensive and systematic review of the plant Euphorbia ebracteolata Hayata, covering its traditional uses, botany, chemical constituents, pharmacological effects, toxicology, and quality control. Specifically:

1. **Traditional Uses and Clinical Applications**: The paper summarizes the applications of E. ebracteolata in traditional medicine, such as treating edema, skin ulcers, abdominal distension, cough, asthma, and tuberculosis, and introduces its modern clinical applications, such as the "Youfuning Capsule" used for treating tuberculosis.

2. **Botanical Characteristics**: It provides a detailed description of the botanical characteristics of E. ebracteolata, including its growth environment, morphological features, and distribution.

3. **Chemical Constituents**: It systematically summarizes 238 compounds isolated and identified from E. ebracteolata, including terpenes, acetophenones, flavonoids, tannins, steroids, volatile oils, etc., and provides a detailed classification and naming of these compounds.

4. **Pharmacological Effects**: It summarizes various pharmacological activities of E. ebracteolata extracts or purified compounds, such as anticancer, anti-inflammatory, antiviral, and antibacterial effects.

5. **Toxicology**: It reports the toxicity of E. ebracteolata, emphasizing safety issues during its use.

6. **Quality Control**: It discusses the quality control methods of E. ebracteolata to ensure its effectiveness and safety in clinical applications.

Through these aspects of the review, the paper aims to provide a comprehensive and up-to-date perspective for future research and points out the current research deficiencies, providing directions for subsequent studies.